BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 68 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,102,135 | -20.9% | 384,019 | +39.2% | 0.00% | – |
| Q2 2023 | $1,393,224 | +498.2% | 275,886 | +123.9% | 0.00% | – |
| Q1 2023 | $232,910 | +96.6% | 123,233 | +87.2% | 0.00% | – |
| Q4 2022 | $118,465 | -73.0% | 65,814 | -74.7% | 0.00% | – |
| Q3 2022 | $439,000 | -33.1% | 259,896 | -2.5% | 0.00% | – |
| Q2 2022 | $656,000 | +266.5% | 266,601 | +313.6% | 0.00% | – |
| Q1 2022 | $179,000 | -79.7% | 64,457 | -60.9% | 0.00% | – |
| Q4 2021 | $880,000 | -12.4% | 164,874 | +38.8% | 0.00% | – |
| Q3 2021 | $1,005,000 | -54.3% | 118,766 | -34.2% | 0.00% | – |
| Q2 2021 | $2,200,000 | -25.7% | 180,449 | +47.9% | 0.00% | – |
| Q1 2021 | $2,961,000 | +385.4% | 122,030 | +542.0% | 0.00% | – |
| Q4 2020 | $610,000 | – | 19,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |